Literature DB >> 16410834

Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells.

Jingsong Wang1, John W Fathman, Geanncarlo Lugo-Villarino, Lucila Scimone, Ulrich von Andrian, David M Dorfman, Laurie H Glimcher.   

Abstract

The transcription factor T-bet (Tbx21) plays a major role in adaptive immunity and is required for optimal IFN-gamma production by DCs. Here we demonstrate an essential function for T-bet in DCs in controlling inflammatory arthritis. We show that collagen antibody-induced arthritis (CAIA), a model of human RA, is a bipartite disease characterized by an early innate immune system component intact in RAG2 mice and a later adaptive immune system phase. Mice lacking T-bet had markedly reduced joint inflammation at both early and late time points and RAG2T-bet double-deficient mice were essentially resistant to disease. Remarkably, adoptive transfer of T-bet-expressing DCs reconstituted inflammation in a T-bet deficient and T-bet/RAG2-deficient milieu. T-bet regulates the production of proinflammatory cytokine IL-1alpha and chemokines macrophage inflammatory protein-1alpha (MIP-1alpha) and thymus- and activation-related chemokine (TARC) by DCs. Further, T-bet expression in DCs is required for T helper cell activation. We conclude that T-bet plays a vital function in DCs that links innate and adaptive immunity to regulate inflammatory responses. T-bet provides an attractive new target for the development of novel therapeutics for inflammatory arthritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16410834      PMCID: PMC1326147          DOI: 10.1172/JCI26631

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

Review 1.  Dendritic cells in experimental allergic encephalomyelitis and multiple sclerosis.

Authors:  H Link; Y M Huang; B G Xiao
Journal:  J Neuroimmunol       Date:  1999-12       Impact factor: 3.478

2.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

3.  Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis.

Authors:  Y Morita; J Yang; R Gupta; K Shimizu; E A Shelden; J Endres; J J Mulé; K T McDonagh; D A Fox
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

4.  T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells.

Authors:  A A Lighvani; D M Frucht; D Jankovic; H Yamane; J Aliberti; B D Hissong; B V Nguyen; M Gadina; A Sher; W E Paul; J J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

5.  Dendritic cells (DCs) in rheumatoid arthritis (RA): progenitor cells and soluble factors contained in RA synovial fluid yield a subset of myeloid DCs that preferentially activate Th1 inflammatory-type responses.

Authors:  F Santiago-Schwarz; P Anand; S Liu; S E Carsons
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

6.  Increased susceptibility of mice lacking T-bet to infection with Mycobacterium tuberculosis correlates with increased IL-10 and decreased IFN-gamma production.

Authors:  Brandon M Sullivan; Ousman Jobe; Vanja Lazarevic; Kristine Vasquez; Roderick Bronson; Laurie H Glimcher; Igor Kramnik
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

7.  Role of T-bet in commitment of TH1 cells before IL-12-dependent selection.

Authors:  A C Mullen; F A High; A S Hutchins; H W Lee; A V Villarino; D M Livingston; A L Kung; N Cereb; T P Yao; S Y Yang; S L Reiner
Journal:  Science       Date:  2001-06-08       Impact factor: 47.728

8.  Infections preceding early arthritis in southern Sweden: a prospective population-based study.

Authors:  Maria K Söderlin; Hannu Kautiainen; Mirja Puolakkainen; Klaus Hedman; Maria Söderlund-Venermo; Thomas Skogh; Marjatta Leirisalo-Repo
Journal:  J Rheumatol       Date:  2003-03       Impact factor: 4.666

9.  Migratory properties of naive, effector, and memory CD8(+) T cells.

Authors:  W Weninger; M A Crowley; N Manjunath; U H von Andrian
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

10.  Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice.

Authors:  R Horai; S Saijo; H Tanioka; S Nakae; K Sudo; A Okahara; T Ikuse; M Asano; Y Iwakura
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

View more
  46 in total

1.  The IL-23/IL-17 axis in inflammation.

Authors:  Yoichiro Iwakura; Harumichi Ishigame
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

2.  Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease.

Authors:  Eugene Y Chiang; Ganesh A Kolumam; Xin Yu; Michelle Francesco; Sinisa Ivelja; Ivan Peng; Peter Gribling; Jean Shu; Wyne P Lee; Canio J Refino; Mercedesz Balazs; Andres Paler-Martinez; Allen Nguyen; Judy Young; Kai H Barck; Richard A D Carano; Ron Ferrando; Lauri Diehl; Devavani Chatterjea; Jane L Grogan
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

Review 3.  T-bet in disease.

Authors:  Vanja Lazarevic; Laurie H Glimcher
Journal:  Nat Immunol       Date:  2011-06-20       Impact factor: 25.606

4.  IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis.

Authors:  Paul D Doodes; Yanxia Cao; Keith M Hamel; Yumei Wang; Rachel L Rodeghero; Katalin Mikecz; Tibor T Glant; Yoichiro Iwakura; Alison Finnegan
Journal:  J Immunol       Date:  2009-12-18       Impact factor: 5.422

5.  IL-36γ/IL-1F9, an innate T-bet target in myeloid cells.

Authors:  Malte Bachmann; Patrick Scheiermann; Lorena Härdle; Josef Pfeilschifter; Heiko Mühl
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

6.  Autoimmunity: increasing suspects in the CD4+ T cell lineup.

Authors:  Matthew T Palmer; Casey T Weaver
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

7.  T-bet expression by dendritic cells is required for the repolarization of allergic airway inflammation.

Authors:  Karin L Heckman; Suresh Radhakrishnan; Tobias Peikert; Koji Iijima; Hugh C McGregor; Michael P Bell; Hirohito Kita; Larry R Pease
Journal:  Eur J Immunol       Date:  2008-09       Impact factor: 5.532

8.  Different regulation of T helper 1- and T helper 2-promoting cytokine signalling factors in human dendritic cells after exposure to protein versus contact allergens.

Authors:  Ingo Böttcher; Iris Bellinghausen; Bettina König; Jürgen Knop; Joachim Saloga
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

9.  Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.

Authors:  Andrew D Cook; Christine M De Nardo; Emma L Braine; Amanda L Turner; Ross Vlahos; Kerrie J Way; S Kaye Beckman; Jason C Lenzo; John A Hamilton
Journal:  Arthritis Res Ther       Date:  2010-03-02       Impact factor: 5.156

10.  T-bet is essential for encephalitogenicity of both Th1 and Th17 cells.

Authors:  Yuhong Yang; Jeffrey Weiner; Yue Liu; Alan J Smith; David J Huss; Ryan Winger; Haiyan Peng; Petra D Cravens; Michael K Racke; Amy E Lovett-Racke
Journal:  J Exp Med       Date:  2009-06-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.